clinical data

The company plans to launch the first version of its AI Advocate tool, aimed at helping patients manage and guide their overall healthcare, in the third quarter of this year.

Data modernization includes how people in public health can have real-time data to inform and provide strategic guidance and policies that can improve communities, says Dr. Sameer Vohra, director of the Illinois Department of Public Health.

Gaurav Sharma, market innovator and global client partner at Cognizant, discusses the balance between accelerating healthcare's use of technology with putting regulations in place to protect patients.  

The company's first two partners to leverage OMNY's dataset are life sciences company ArisGlobal and clinical trial design company QuantHealth.

McGill University Health Centre's Dr. Alan Forster discusses the Quadruple Aim and using data to understand opportunities for development and improvement.  

Ziv Ofek, cofounder and CEO of MDClone, discusses how GenAI tools may soon make it easier for clinicians to analyze synthetic data themselves if guardrails are in place to ensure that the AI's conclusions are correct.  

Ansys industry director for Healthcare Solutions Thierry Marchal and researcher María Angeles Pérez discuss how combining clinical data and mathematical models can increase precision and expedite treatment plans.  

The company will use the funds to enter into strategic relationships with life sciences organizations focusing on oncology and specialty care.

Johns Hopkins has been moving into AI to create datasets and data models, says Luis Ahumada, director of health data science and analytics at Johns Hopkins All Children’s Hospital. Data collection and validation have been incremental.  

Sara Shanti, partner at Sheppard Mullin, discusses the intersection of healthcare and technology, how to establish trust and transparency within AI, and questions she receives pertaining to virtual therapy, particularly in mental health.